Skip to content

Clinical trials

Phase 4 Alzheimer Disease trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Alzheimer Disease Phase: Phase 4 Country / region: China Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20141
20151
20161
20212
20232
20241
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Active, not recruiting3
Recruiting3
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Green Valley (Shanghai) Pharmaceuticals Co., Ltd.3
Beijing Friendship Hospital1
First Affiliated Hospital of Wenzhou Medical University1
H. Lundbeck A/S1
Novartis Pharmaceuticals1
Ruijin Hospital1
Shanghai Mental Health Center1
The Fourth Affiliated Hospital of Zhejiang University School of Medicine1
Xiangya Hospital of Central South University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Alzheimer Disease11
Epilepsy1
Frontotemporal Dementia1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.